Duloxetine in the treatment of stress urinary incontinence. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. Pharmacoepidemiol Drug Saf 2002 11: 271–9 Selective serotonin reuptake inhibitor-induced urinary incontinence. Movig KL, Leufkens HG, Belitser SV, et al. Venlafaxine and urinaryincontinence: possibleassociation. Int Urogynecol J Pelvic Floor Dysfunct 2000 11: 386–8Ĭavanaugh GL, Martin RE, Stenson MA, et al. Serotonergic antidepressants and urinary incontinence. Treatment of overactive bladder: other drug mechanisms. Clin Pharmacol Ther 2002 72: 729–34Īndersson KE. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. Olanzapine-induced urinary incontinence: treatment with ephedrine.

Incidence of risperidone induced incontinence. A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. Montvale (Nj): Medical Economics, 1999: 2004–8įuller MA, Borovicka MC, Jaskiw GE, et al.

J Clin Psychol 1979 40: 271–4Ĭlozaril (clozapine). Urinary incontinence in patients receiving neuroleptics. Enuresis and incontinence occurring with neuroleptics. JAMA 1971 218: 738Īmbrosini PJ, Nurnberg HG. A pharmacologic paradigm for urinary incontinence and enuresis. Phenothiazine-induced stress incontinence. Temporary urinary incontinence in the acute psychiatric patient without delusion or dementia. Naunyn-Schmiedebergs Arch Pharmacol 2007 374: 385–98īerrios GE. β-Adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility. Alpha-adrenergic blockade and urinary incontinence. Analyses of the urethral pressure profile by means of electromyography and the administration of drugs. Obstet Gynaecol 1992 79: 117–21ĭonker PJ, Ivanovici F, Noach EL. Prazosin: a neglected cause of stress incontinence. Br J Urol 1993 72: 510ĭwyer PL, Teele JS. Genuine stress incontinence induced by prazosin. Prazosin as cause of urinary incontinence. Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting enzyme inhibitors. Urinary incontinence secondary to prazosin. The place of alpha-blocking drugs in the treatment of children with neuropathic bladders. Assessment and treatment of urinary incontinence.

Scientific Committee of the First International Consultation on Incontinence. Risk factors for incontinence in nursing home: a multivariate study. Innervation and function of the female urinary bladder and urethra. Eur Urol Suppl 2005 4: 18–28īannowsky A, Juenemann KP. Negative impact of urinary incontinence on quality of life, a cross-sectional study among women aged 49–61 years enrolled in the GAZEL cohort. Fraction of nursing home admissions attributable to urinary incontinence. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol 2006 Nov 176: 2103–8Īnger JT, Saigal CS, Litwin MS, et al.

The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination Survey. However, other drug classes are not innocent in terms of causing urinary incontinence and physicians are well advised to closely monitor patients for the occurrence of incontinence after new prescriptions and/or major dosage changes.Īnger JT, Saigal CS, Stothers L, et al. Drug classes in which induction of incontinence has been proposed include α 1-adrenoceptor antagonists, antipsychotics, benzodiazepines, antidepressants and hormone replacement therapy in postmenopausal women. While many drug groups could theoretically induce urinary incontinence based upon pathophysiological considerations, evidence demonstrating a cause-effect relationship between drug usage and incontinence is sparse. In principle, drugs could cause incontinence by lowering bladder outlet resistance and/or by increasing intravesical pressure, which disrupts the normal pressure relationship between the bladder and urethra and leads to urinary leakage other possibilities include disturbances of central nervous control of voiding or an overproduction of urine. Physiological urinary continence depends on many factors that are potentially vulnerable to adverse drug effects, which may lead to incontinence.

Overflow incontinence sdn